Search
Azenta Inc
AZTAAdd to Watchlist
23.310USD
+0.635+2.80%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.07BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Azenta Inc is 7.43, ranking 294 out of 389 in the Biotechnology & Medical Research industry. The average price target is 41.00, with a high of 45.00 and a low of 31.00.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
28.500
Target Price
+22.27%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Azenta Inc
AZTA
7
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Azenta Inc's expected revenue for the next quarter?
Azenta Inc's expected revenue is 149.29M.
What is Azenta Inc's price target?
Analysts forecast that Azenta Inc's price target is USD 41.00, with the highest forecast at USD 45.00 and the lowest forecast at USD 31.00.
How have Azenta IncAZTA's recent earnings per share performed?
The market expectation was USD -3.49, while Azenta IncAZTA's earnings per share (EPS) for the previous quarter was USD -0.34. EPS for the next quarter is expected at USD 0.10.
What is the analyst rating for Azenta Inc?
Based on the ratings of Azenta Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
